Compassionate use and hospital exemption for regenerative medicine: Something wrong to apply the program for patients in a real world - PMC
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. “Compassionate use” or “Hospital exemption” provides an important pathway for patients with life-threatening conditions to gain access to unproved human cells and tissue products. In a real world, any practitioners may not comply with relevant system. Such regulation should establish an international registry of clinical practices of stem cell therapy as well as provide education for patients to prevent deception by the spread of misinformation by testimonials on websites. We read the World Report titled “The dangers of unregulated stem-cell market
Regen Ther . 2018 Apr 7;8:63–64. doi: 10.1016/j.reth.2018.03.002 Compassionate use and hospital exemption for regenerative medicine: Something wrong to apply the program for patients in a real world Kazuo Yano Kazuo Yano 1 Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan Find articles by Kazuo Yano 1, 1 , Masayuki Yamato Masayuki Yamato 1 Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan Find articles by Mas
Explore this link on the map →related reading
- Medicine's Endgamenotboring.co
- The Island Where People Go to Cheat Death | The New Republicnewrepublic.com
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Who regulates the regulators?rootsofprogress.org
- Complementary Medicine | UW Department of Bioethics & Humanitiesdepts.washington.edu
- Biotech’s Lost Archive | IFPifp.org
- The blood cancer that became solvableworksinprogress.news
- Pearl Freier on X: "Cell & gene therapies were 2.5x more likely to receive FDA approval after entering Phase 1 than other drug types according to research by the NEWDIGs initiative at Tufts Medical Center h/t @DrPHanley & @alliancerm . @NatRevDrugDisc paper below 1/n https://t.co/DN4k7qWrAt" / Xx.com
- Systemic Bottlenecks & Misalignmentscurecancer.ai
- FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
- Curative gene therapies for rare diseases - PMCncbi.nlm.nih.gov
- Medical AI Safety: We have a problem. – Lauren Oakden-Raynerlaurenoakdenrayner.com